Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.17 USD | +5.11% | +30.03% | +38.34% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
Financials (USD)
Sales 2024 * | 68.34M | Sales 2025 * | 84.72M | Capitalization | 955M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -108M | EV / Sales 2024 * | 14 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 11.3 x |
P/E ratio 2024 * |
-7.08
x | P/E ratio 2025 * |
-7.17
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.08% |
Latest transcript on Ocular Therapeutix, Inc.
1 day | +5.11% | ||
1 week | +30.03% | ||
Current month | +30.17% | ||
1 month | -26.98% | ||
3 months | +19.11% | ||
6 months | +89.26% | ||
Current year | +38.34% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 17-09-24 |
Chief Tech/Sci/R&D Officer | - | 21-09-27 | |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 23-07-09 |
Director/Board Member | 76 | 12-11-04 | |
Merilee Raines
BRD | Director/Board Member | 68 | 21-09-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.90% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 6.17 | +5.11% | 4,643,067 |
24-05-02 | 5.87 | +16.93% | 3,479,674 |
24-05-01 | 5.02 | +5.91% | 3,033,532 |
24-04-30 | 4.74 | -1.25% | 2,000,147 |
24-04-29 | 4.8 | +1.16% | 3,796,005 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.34% | 955M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- OCUL Stock